novel coronavirus pneumonia (COVID-19)
Conditions
Interventions
placebo group:placebo
Sponsors
Zhejiang Chinese Medical University
Eligibility
Sex/Gender
All
Age
14 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Conforming to the diagnostic criteria of suspected cases (Chiese medicine observation period) in the fourth edition of pneumonia diagnosis and treatment program for new coronavirus infection issued by the national health and health commission; (2) Age between 14 and 80 years old; (3) Patients informed and agreed to participate in the study.
Exclusion criteria
Exclusion criteria: (1) Patients are not suitable to take Chinese medicine decoction. (2) Patients have other serious organ disease or mental illness; (3) Patients allergy or have contraindications to the drugs involved in the research program.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relief of clinical symptoms and duration; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression rate of 2019-nCoV pneumonia;Rate of severe pneumonia or death in people who progress to 2019-nCoV pneumonia; | — |
Countries
China
Contacts
Public ContactChengping Wen
Zhejiang Chinese Medical University
Outcome results
None listed